Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT for Parkinsons Disease
December 05, 2025 08:00 ET | Source: Amneal Pharmaceuticals LLC Interim data…
NobleAI Appoints Alex Wang as Chief Executive Officer to Lead Next Phase of Growth and Innovation
SAN FRANCISCO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- NobleAI, the leader in…
Signing Day Sports Shareholder Letter Details AI/HPC Infrastructure Opportunity with BlockchAIn Digital Infrastructure
SCOTTSDALE, AZ, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc.…
New 2026 L&D Report Shows AI Adoption Outpacing Workforce Readiness, Critical Thinking, Leadership, and Mentorship Needs
CALGARY, Alberta, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Together, the mentorship and…
Ascent Cloud Announces Winter 2026 Release of its Sales Performance Management Solutions
DETROIT, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Ascent Cloud has announced the…
McLaren Bay Region Raises the Bar on Emergency Department Communication with MEDI+SIGN
BAY CITY, Mich., Dec. 04, 2025 (GLOBE NEWSWIRE) -- McLaren Bay Region…
Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine
AGOURA HILLS, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc.…
69% surge in entrepreneurs signals new era of growth
LinkedIn’s latest research reveals small businesses are entering 2026 with confidenceAuthenticity and…
Exosens and Theon extend long-term commercial agreement through 2030 to secure image intensifier tube capacity in a market constrained by growing demand
EXOSENS AND THEON EXTEND LONG-TERM COMMERCIAL AGREEMENT THROUGH 2030 TO SECURE IMAGE…
Nika Pharmaceuticals, Inc. (NIKA) Progress Update
HENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB:…